[1] SHE D, WANG Y, LIU J, et al. Changes in the prevalence of hyperuricemia in clients of health examination in Eastern China, 2009 to 2019[J]. BMC Endocr Disord, 2022, 22(1): 202. [2] 顾汝英, 李娟, 陈燕, 等. 社区视角下老年人群高尿酸血症与慢性代谢性疾病的相关性分析[J]. 中华全科医学, 2024, 22(8): 1283-1286. [3] TIAN X, CHEN S, WANG P, et al. Temporal relationship between hyperuricemia and hypertension and its impact on future risk of cardiovascular disease[J]. Eur J Intern Med, 2023, 111: 82-89. [4] YANAI H, ADACHI H, HAKOSHIMA M, et al. Molecularbiological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease[J]. Int J Mol Sci, 2021, 22(17): 9221. [5] KUWABARA M, KODAMA T, AE R, et al. Update in uric acid, hypertension, and cardiovascular diseases[J]. Hypertens Res, 2023, 46(7): 1714-1726. [6] XIA Y, XIA C, WU L, et al. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42, 875 US adults[J]. J Clin Med, 2023, 12(3): 1128. [7] ZHOU E, WU J, ZHOU X, et al. Systemic inflammatory biomarkers are novel predictors of all-cause and cardiovascular mortality in individuals with osteoarthritis: a prospective cohort study using data from the NHANES[J]. BMC Public Health, 2024, 24(1): 1586. [8] CAO Y, ZHENG X, HU Y, et al. Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer[J]. Cell Death Dis, 2023, 14(1): 69. [9] SUN L, HU W, LIU M, et al. High systemic inflammation response index (SIRI) indicates poor outcome in gallbladder cancer patients with surgical resection: a single institution experience in China[J]. Cancer Res Treat, 2020, 52(4): 1199-1210. [10] WANG R H, WEN W X, JIANG Z P, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage[J]. Front Immunol, 2023, 14: 1115031. [11] HAN K, SHI D, YANG L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention[J]. Ann Med, 2022, 54(1): 1667-1677. [12] JIN Z, WU Q, CHEN S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85, 154 individuals[J]. J Inflamm Res, 2021, 14: 131-140. [13] LIU B, WANG J, LI Y Y, et al. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999-2018[J]. Arthritis Res Ther, 2023, 25(1): 34. [14] HARDING M C, SLOAN C D, MERRILL R M, et al. Transitions from heart disease to cancer as the leading cause of death in US states, 1999—2016[J]. Prev Chronic Dis, 2018, 15: E158. [15] HUA X, DUAN F, ZHAI W, et al. A novel inflammatory-nutritional prognostic scoring system for patients with early-stage breast cancer[J]. J Inflamm Res, 2022, 15: 381-394. [16] GUPTA L, THOMAS J, RAVICHANDRAN R, et al. Inflammation in cardiovascular disease: a comprehensive review of biomarkers and therapeutic targets[J]. Cureus, 2023, 15(9): e45483. [17] HUANG Y W, ZHANG Y, FENG C, et al. Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis[J]. Eur J Med Res, 2023, 28(1): 474. [18] GIGANTE A, PELLICANO C, GALLICCHIO C, et al. Serum uric acid/serum creatinine ratio and chronic vascular lesions on renal biopsy: a retrospective observational study[J]. High Blood Press Cardiovasc Prev, 2025, 32(2): 165-170. [19] XU X, ZHANG B, WANG Y, et al. Renal fibrosis in type 2 cardiorenal syndrome:an update on mechanisms and therapeutic opportunities[J]. Biomed Pharmacother, 2023, 164: 114901. |